Report estimates proportion of U.S. adults with HIV not adhering to medication due to cost

This observational report examined the proportion of U.S. adults with HIV infection who did not adhere to any prescribed medication due to costs during the period from May 2016 to June 2017. The study population consisted of U.S. adults with human immunodeficiency virus, though the specific sample size was not reported. No intervention, comparator, or specific setting details beyond the United States were provided.

The primary outcome was the proportion of this population who did not adhere to medication due to cost. However, the abstract does not report any main results, including the estimated proportion, absolute numbers, effect sizes, p-values, or confidence intervals. The direction of any association was also not reported. No secondary outcomes were mentioned.

No safety or tolerability data regarding adverse events, serious adverse events, or discontinuations were reported. The abstract did not include information on study limitations, funding sources, or conflicts of interest. The practice relevance of the findings was not specified.

Given the observational design, any findings would represent associations rather than causation. The complete absence of reported quantitative results in the abstract significantly limits interpretation. Clinicians should await the full publication for specific estimates and methodological details before drawing conclusions about cost-related nonadherence in this population.